Biotech braces for busy summer

Cristin FlanaganBloombergInvestors may be digesting a deal from Bristol-Myers Squibb for Celgene and getting their teeth into AbbVie's bid for Allergan, but there are plenty of other large-cap biotechs and pharma still hungry for action.
"Do not sleep on the summer," Jefferies trading specialist Jared Holz cautioned clients in a note.Read more on NewsOK.com


Warning: ksort() expects parameter 1 to be array, object given in /home/infopult/news.info-pult.com/wp-content/plugins/yet-another-related-posts-plugin/classes/YARPP_Cache.php on line 462

Cristin Flanagan
Bloomberg

Investors may be digesting a deal from Bristol-Myers Squibb for Celgene and getting their teeth into AbbVie's bid for Allergan, but there are plenty of other large-cap biotechs and pharma still hungry for action.

"Do not sleep on the summer," Jefferies trading specialist Jared Holz cautioned clients in a note.
Read more on NewsOK.com

Read more on Newsok 

Share Button

Leave a Reply

Your email address will not be published. Required fields are marked *